title: Decrease of plasma apolipoprotein A-IV during weight reduction in obese adolescents on a low fat diet.
abstract: OBJECTIVE
  Apolipoprotein (apo) A-IV is an antiatherogenic apolipoprotein, which may be involved in the regulation of food intake. Plasma apoA-IV is elevated in human obesity and apoA-IV polymorphisms have been associated with the extent of obesity. Our aim was to determine the effects of weight loss on plasma apo-IV in obese adolescents and to examine the relation of apoA-IV with the degree of obesity.
  
  
  METHODS
  Longitudinal intervention study of a low fat hypocaloric diet conducted in a dietary camp.
  
  
  METHODS
  Two groups of obese adolescents (n=47 and n=29), age: 12.7+/-1.7 and 11.7+/-2.6 y, relative body mass index (RBMI): 168+/-24 and 175+/-34%, respectively.
  
  
  METHODS
  Plasma total apoA-IV, apoA-I, apoB, plasma distribution of apoA-IV, leptin, lipids, and lipoproteins before and after 3 weeks of weight reduction.
  
  
  RESULTS
  Plasma apoA-IV decreased from 11.5+/-4.1 mg/dl before to 6.7+/-2.2 mg/dl after weight reduction in the first group (P<0.001) and to a similar extent in the second group. The relative amount of lipid-free apoA-IV and apoA-IV associated with apoA-I increased slightly, whereas apoA-IV associated with lipoproteins devoid of apoA-I decreased. ApoA-IV levels before and after weight reduction and the changes in plasma apoA-IV did not independently correlate with RBMI, weight loss, or plasma leptin.
  
  
  CONCLUSIONS
  Plasma apoA-IV decreases markedly in overweight adolescents undergoing short-term weight reduction. The decrease is not directly related to the degree of weight loss and the mechanisms underlying this reduction remain to be clarified.
authors.affiliation: Institute of Medical Biology and Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.
authors.forename: A
authors.initials: A
authors.lastname: Lingenhel
authors.forename: C
authors.initials: C
authors.lastname: Eder
authors.forename: K
authors.initials: K
authors.lastname: Zwiauer
authors.forename: H
authors.initials: H
authors.lastname: Stangl
authors.forename: F
authors.initials: F
authors.lastname: Kronenberg
authors.forename: W
authors.initials: W
authors.lastname: Patsch
authors.forename: W
authors.initials: W
authors.lastname: Strobl
mesh_terms: D000293:Adolescent; D016632:Apolipoprotein A-I / Q000097:blood; D001054:Apolipoproteins A / Q000097:blood*; D002648:Child; D004041:Dietary Fats / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D009765:Obesity / Q000097:blood* / Q000178:diet therapy* / Q000503:physiopathology; D012044:Regression Analysis; D015431:Weight Loss
chemical_list: D016632:Apolipoprotein A-I; D001054:Apolipoproteins A; D004041:Dietary Fats; C022205:apolipoprotein A-IV